Clear Search sequence regions


  • aspirin (9)
  • asthma (2)
  • humans (1)
  • mast cells (7)
  • nasal polyps (1)
  • nsaid (1)
  • pathogenesis (1)
  • phase (1)
  • Sizes of these terms reflect their relevance to your search.

    Aspirin-exacerbated respiratory disease (AERD) is a syndrome of high type 2 inflammation and is known to critically involve mast cell activation. The mast cell is an important cell in the baseline inflammatory processes in the upper and lower airway by maintaining and amplifying type 2 inflammation. But it also is prominent in the hypersensitivity reaction to COX-1 inhibition which defines this condition. Recent work highlights the mast cell as a focal point in AERD pathogenesis. Using AERD as a specific model of both high type 2 asthma and chronic sinusitis, the role of mast cell activity can be better understood in other aspects of airway inflammation. Further dissecting out the mechanism of COX-1-mediated mast cell activation in AERD will be an important next phase in our understanding of NSAID-induced hypersensitivity as well as AERD pathophysiology. © 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

    Citation

    Edsel M Abud, Andrew A White. Mast Cells in Aspirin-Exacerbated Respiratory Disease. Current allergy and asthma reports. 2024 Feb;24(2):73-80

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38217825

    View Full Text